维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Tzeis S"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Safety of implantable pacemakers and cardioverter defibrillators in the magnetic field of a novel remote magnetic navigation system显示文摘	Jilek C Tzeis S Reents T	2010	J Cardiovasc Electrophysiol2010，21，10：	1
2	Dobutamine administration exacerbates postischaemic myocardial dysfunction in isolated rat hearts:an effect reversed by thyroxine pretreatment显示文摘	Pantos C Mourouzis I Tzeis S	2003	Eur J Pharmacol2003，460，：	1
3	Erythropoietin in heart failure and other cardiovascular diseases:hematopoietic and pleiotropic effects显示文摘	Manolis AS Tzeis S Triantafyllou K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，：	1
4	Erythropoietin in heart failure and other cardiovascular diseases hematopoietic and pleio- tropic effects显示文摘	Manolis AS Tzeis S Triantafylou K	2005	Curr Drug Targets Cardiovascu Haematol Dis- ord2005，5，5：	1
5	Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects 显示文摘	Manolis AS Tzeis S Triantafyllou K	2005	Curr Drug Targets Cardiovase Haematol Disord2005，5，5：	1
6	Monitoring capabil-ities of cardiac rhythm management devices显示文摘	Andrikopoulos G Tzeis S Theodorakis G	2010	Europace2010，12，1：	1
7	Erythropoietin in heart failure and other cardio-vascular diseases : hematopoietic and pleiotropic effects显示文摘	MANOLIS A S TZEIS S TRIANTAFYLLOU K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，：	1
8	Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects 显示文摘	Manolis AS Tzeis S Triantafyllou K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，：	1
9	Erythropoietin in heart failure and other cardiovascular diseases:hematopoietic and pleiotropic effects显示文摘	Manolis AS Tzeis S Triantafyllou K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，5：	1
10	Antiarrhythmic properties of ranolazine-from bench to bedside显示文摘	TZEIS S RIKOPOULOS G	2012	Expert Opin Investig Drugs2012，21，11：	1
11	Erythropoietin in heart failure and other eardiovascu- lax diseases : hematopoietic and pleiotropie effects 显示文摘	MANOLIS A S TZEIS S TRIANTAFYLLOU K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，5：	1
12	Erythropoietin in heart failure and other cardiovascular diseases:hematopoietic and pleiotropic effects显示文摘	Manolis A S Tzeis S Triantafyllou K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，5：	1
13	Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks显示文摘	Tzeis S Andrikopoulos G Kolb C	2008	Europace2008，10，11：	1
14	Cardiac resynchronisation therapy in heart failure patients with narrow QRS complex: quo vadis? 显示文摘	Andrikopoulos GK Tzeis S Manolis AS	2007	Hellenic J Cardiol2007，48，6：	1
15	Transseptal cathe- terization: considerations and caveats显示文摘	Tzeis S Andrikopoulos G Deisenhofer I	2010	Pacing Clin Eleetrophysi- ol2010，33，2：	1
16	Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects 显示文摘	Manolis AS Tzeis S Triantafyllou K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，：	1
17	Erythropoietin in heart failure and other cardiovascular diseases : hematopoietic and pleiotropic effects 显示文摘	MANOLIS A S TZEIS S TRIANTAFYLLOU K	2005	Curr Drug Targets Cardiovasc Haematol Disord2005，5，5：	1
18	Aspirin and clopi- dogrel:a sweeping combination in cardiology 显示文摘	Manolis AS Tzeis S Andrikopoulos G	2005	Curt Med Chem Cardiovasc Hematol Agents2005，3，3：	1
19	Transseptal cathe- terization: considerations and caveats显示文摘	Tzeis S Andrikopoulos G Deisenhofer l	2010	Pacing Clin Electrophysi- ol2010，33，2：	1
20	Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischaemic contracture in hyperthyroidhearts显示文摘	Pantos C Mourouzis I Tzeis S	2000	J Cardiovasc Pharmacol2000，36，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示